Graf Acquisition Corp. IV

  • Investors
  • Overview
  • SEC Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Our Team
    • Management
    • Prior SPAC Experience
  • Contact Us

Press Releases

News

News

  • Press Releases
  • In The News
Sep 22, 2023 8:31am EDT

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023

Sep 14, 2023 9:00am EDT

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 20, 2023

Sep 11, 2023 11:08am EDT

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023

Aug 30, 2023 7:00am EDT

Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 8, 2023

Aug 15, 2023 12:07pm EDT

Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination

May 16, 2023 9:56pm EDT

Graf Acquisition Corp. IV Currently Has Proxies from More Than 65% of its Stockholders to Approve Extension

May 02, 2023 4:35pm EDT

NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

Apr 14, 2023 8:19pm EDT

NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV

Mar 23, 2023 5:51pm EDT

Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination

Dec 16, 2022 9:30am EST

Graf Acquisition Corp. IV Withdraws Extension Proposal

  • 1
  • 2
  • Next
RSS
  • Email Alerts
  • RSS News Feed
© 2023 Graf Acquisition Corp. IV. All Rights Reserved.
Privacy Notice Terms of Use Sitemap